Literature DB >> 9317154

The role of IFN regulatory factor-1 in synovitis and nitric oxide production.

A Shiraishi1, J Dudler, M Lotz.   

Abstract

The IFN regulatory factor-1 (IRF-1) DNA binding protein regulates expression of genes that are involved with the induction of immune and inflammatory responses. The present study used mice with a targeted disruption of the IFN regulatory factor-1 gene (IRF-1-/-) to examine the role of this transcription factor in synovial inflammation and nitric oxide production. Intraarticular injection of IL-1 or LPS was associated with a significantly reduced intensity of synovial lining hyperplasia and leukocyte infiltration in the IRF-1-/- mice as compared with wild-type mice of the same parental lineage C57BL/6. Nitric oxide (NO) is involved with the pathogenesis of arthritis, and IRF-1 regulates expression of inducible NO synthase (iNOS) in mononuclear phagocytes. Articular chondrocytes from IRF-1-/- mice produced similar levels of NO in response to IL-1 or LPS. Furthermore, the synergistic induction of NO by IFN-gamma and IL-1 or LPS was almost identical in chondrocytes from wild-type and IRF-1-/- mice. This was in contrast to the expected decrease in NO production by peritoneal macrophages from IRF-1-/- mice, suggesting that IRF-1 is not required for iNOS expression in chondrocytes. These results indicate that IRF-1 has a tissue-specific role in the induction of iNOS. Inhibition of this transcription factor may represent a novel approach in controlling inflammatory diseases such as arthritis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317154

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds.

Authors:  Eric Mahoney; Jonathan Reichner; Leslie Robinson Bostom; Balduino Mastrofrancesco; William Henry; Jorge Albina
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

2.  Complex regulation of human inducible nitric oxide synthase gene transcription by Stat 1 and NF-kappa B.

Authors:  R W Ganster; B S Taylor; L Shao; D A Geller
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

Review 3.  Does nitric oxide play a critical role in viral infections?

Authors:  C S Reiss; T Komatsu
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

4.  A benzamide-linked small molecule HS-Cf inhibits TNF-α-induced interferon regulatory factor-1 in porcine chondrocytes: a potential disease-modifying drug for osteoarthritis therapeutics.

Authors:  Feng-Cheng Liu; Hsu-Shan Huang; Chuan-Yueh Huang; Ro Yang; Deh-Ming Chang; Jenn-Haung Lai; Ling-Jun Ho
Journal:  J Clin Immunol       Date:  2011-08-20       Impact factor: 8.317

5.  Computational design and application of endogenous promoters for transcriptionally targeted gene therapy for rheumatoid arthritis.

Authors:  Jeroen Geurts; Leo A B Joosten; Nozomi Takahashi; Onno J Arntz; Anton Glück; Miranda B Bennink; Wim B van den Berg; Fons A J van de Loo
Journal:  Mol Ther       Date:  2009-08-18       Impact factor: 11.454

6.  Estrogen regulates transcription factors STAT-1 and NF-kappaB to promote inducible nitric oxide synthase and inflammatory responses.

Authors:  Rujuan Dai; Rebecca A Phillips; Ebru Karpuzoglu; Deena Khan; S Ansar Ahmed
Journal:  J Immunol       Date:  2009-11-04       Impact factor: 5.422

7.  Gene expression analysis of rheumatoid arthritis synovial lining regions by cDNA microarray combined with laser microdissection: up-regulation of inflammation-associated STAT1, IRF1, CXCL9, CXCL10, and CCL5.

Authors:  S Yoshida; F Arakawa; F Higuchi; Y Ishibashi; M Goto; Y Sugita; Y Nomura; D Niino; K Shimizu; R Aoki; K Hashikawa; Y Kimura; K Yasuda; K Tashiro; S Kuhara; K Nagata; K Ohshima
Journal:  Scand J Rheumatol       Date:  2012-03-09       Impact factor: 3.641

8.  Down-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1.

Authors:  Tiina Leppänen; Riku Korhonen; Mirka Laavola; Riina Nieminen; Raimo K Tuominen; Eeva Moilanen
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.